TOWA Pharmaceutical (Osaka) Overview
- Year Founded
-
1951
- Status
-
Public
- Employees
-
5,642
- Stock Symbol
-
4553
- Investments
-
11
- Share Price
-
$21.16
- (As of Thursday Closing)
TOWA Pharmaceutical (Osaka) General Information
Description
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
Contact Information
Website
www.towayakuhin.co.jpCorporate Office
- 2-11, Shinbashi-cho
- Kadoma
- Osaka, 571-8580
- Japan
Corporate Office
- 2-11, Shinbashi-cho
- Kadoma
- Osaka, 571-8580
- Japan
TOWA Pharmaceutical (Osaka) Stock Performance
As of 12-Nov-2026, TOWA Pharmaceutical (Osaka)’s stock price is $21.16. Its current market cap is $1.04B with 49.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $21.16 | $21.80 | $18.35 - $28.42 | $1.04B | 49.2M | 122K | $0.49 |
TOWA Pharmaceutical (Osaka) Financials Summary
As of 30-Sep-2026, TOWA Pharmaceutical (Osaka) has a trailing 12-month revenue of $1.81B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,325,996 | 2,445,900 | 2,179,239 | 2,026,640 |
| Revenue | 1,813,960 | 1,815,957 | 1,702,277 | 1,577,509 |
| EBITDA | 225,862 | 251,810 | 313,676 | 298,962 |
| Net Income | 24,793 | 34,832 | 124,500 | 111,932 |
| Total Assets | 3,077,203 | 2,973,201 | 3,146,322 | 2,845,411 |
| Total Debt | 1,459,413 | 1,418,353 | 1,543,567 | 1,343,297 |
TOWA Pharmaceutical (Osaka) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TOWA Pharmaceutical (Osaka) Patents
TOWA Pharmaceutical (Osaka) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026178272-A | Methods and uses for stabilizing sitagliptin phosphate anhydrous oral formulations | Pending | 18-Aug-2026 | ||
| JP-3255997-U | Ptp packaging material | Active | 30-Mar-2026 | ||
| JP-2026173565-A | Pharmaceuticals | Pending | 17-Apr-2025 | ||
| JP-2026135916-A | A medicine containing sitagliptin | Pending | 13-Feb-2025 | ||
| JP-2026122683-A | Pharmaceutical composition, method for producing the same, and method for stabilizing the pharmaceutical composition | Pending | 16-Jan-2025 |
TOWA Pharmaceutical (Osaka) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TOWA Pharmaceutical (Osaka) Investments & Acquisitions (11)
TOWA Pharmaceutical (Osaka)’s most recent deal was a Merger/Acquisition with Tanabe Pharma Factory Co.. The deal was made on 03-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tanabe Pharma Factory Co. | 03-Jul-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Sunsho Pharmaceutical | 01-Mar-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Protosera | 01-Jan-2021 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Pensa Investments | 31-Jan-2020 | Merger/Acquisition | Other Healthcare Services | ||
| Greencaps Pharmaceutical | 01-Jan-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
TOWA Pharmaceutical (Osaka) ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.75 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
TOWA Pharmaceutical (Osaka) Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Greencaps Pharmaceutical | Fujinomiya, Japan | 2016 | |
| Protosera | Settsu, Japan | 2004 | |
| Yoshida Jimusho | Osaka, Japan | 1994 | |
| Sunsho Pharmaceutical | Fuji, Japan | 1993 | |
| J-Dolf Pharmaceutical | Koka, Japan | 1965 |
TOWA Pharmaceutical (Osaka) FAQs
-
When was TOWA Pharmaceutical (Osaka) founded?
TOWA Pharmaceutical (Osaka) was founded in 1951.
-
Where is TOWA Pharmaceutical (Osaka) headquartered?
TOWA Pharmaceutical (Osaka) is headquartered in Osaka, Japan.
-
What is the size of TOWA Pharmaceutical (Osaka)?
TOWA Pharmaceutical (Osaka) has 5,642 total employees.
-
What industry is TOWA Pharmaceutical (Osaka) in?
TOWA Pharmaceutical (Osaka)’s primary industry is Pharmaceuticals.
-
Is TOWA Pharmaceutical (Osaka) a private or public company?
TOWA Pharmaceutical (Osaka) is a Public company.
-
What is TOWA Pharmaceutical (Osaka)’s stock symbol?
The ticker symbol for TOWA Pharmaceutical (Osaka) is 4553.
-
What is the current stock price of TOWA Pharmaceutical (Osaka)?
As of 12-Nov-2026 the stock price of TOWA Pharmaceutical (Osaka) is $21.16.
-
What is the current market cap of TOWA Pharmaceutical (Osaka)?
The current market capitalization of TOWA Pharmaceutical (Osaka) is $1.04B.
-
What is TOWA Pharmaceutical (Osaka)’s current revenue?
The trailing twelve month revenue for TOWA Pharmaceutical (Osaka) is $1.81B.
-
What is TOWA Pharmaceutical (Osaka)’s annual earnings per share (EPS)?
TOWA Pharmaceutical (Osaka)’s EPS for 12 months was $0.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
